{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:05:23Z","timestamp":1781060723135,"version":"3.54.1"},"reference-count":24,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":973,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/j.1529-8019.2012.01538.x","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T14:04:14Z","timestamp":1360073054000},"page":"73-76","source":"Crossref","is-referenced-by-count":9,"title":["Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis"],"prefix":"10.1155","volume":"26","author":[{"given":"Valentina","family":"Broshtilova","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology; Faculty of Medicine; Sofia Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Iliev","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; Faculty of Medicine; Sofia Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Gantcheva","sequence":"additional","affiliation":[{"name":"Institute of Experimental Morphology, Pathology and Anthropology with Museum; Bulgarian Academy of Science; Sofia; Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0001|dth1538-cit-0001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18553\/jmcp.2011.17.s9-b.S14","article-title":"Biological agents in rhuematoid arthritis: an update for managed care professionals","volume":"17","author":"Agarwal","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0002|dth1538-cit-0002","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4137\/CCRep.S8150","article-title":"Treatment with etanercept in a patient with rheumatoid arthritis-associated interstitial lung disease","volume":"4","author":"Wang","year":"2011","journal-title":"Clin Med Insights Case Rep"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0003|dth1538-cit-0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2005.042416","article-title":"Current state of tumor necrosis factor a blockade in Wegener's granulomatosis","volume":"64","author":"Mukhtyar","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0004|dth1538-cit-0004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.rdc.2004.01.004","article-title":"Treatment of rheumatoid arthritis with etanercept","volume":"30","author":"Genovese","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0005|dth1538-cit-0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MOO.0b013e3281568b96","article-title":"Wegener's granulomatosis: current trends in diagnosis and management","volume":"15","author":"Erickson","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0006|dth1538-cit-0006","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2249.1991.tb05737.x","article-title":"Tumour necrosis factor\/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice","volume":"85","author":"Deguchi","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0007|dth1538-cit-0007","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.160.7.3602","article-title":"Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: revearsal with Il-10","volume":"160","author":"Ludviksson","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0008|dth1538-cit-0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1999.00799.x","article-title":"Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane","volume":"115","author":"De Bandt","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0009|dth1538-cit-0009","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.ki.5000167","article-title":"IL-18 is upregulated in kidney and primes neutrophil responsiveness in ANCA-associated vasculitis","volume":"69","author":"Hewins","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0010|dth1538-cit-0010","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMc1001343","article-title":"Mixed lymphohematopoietic chimerism and response in Wegener's granulomatosis","volume":"362","author":"Bornhauser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0011|dth1538-cit-0011","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ncprheum0825","article-title":"Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases","volume":"4","author":"Langford","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0012|dth1538-cit-0012","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","article-title":"Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha","volume":"64","author":"Eriksson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0013|dth1538-cit-0013","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials","volume":"43","author":"Charles","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0014|dth1538-cit-0014","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.11033","article-title":"Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis","volume":"48","author":"Carlson","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0015|dth1538-cit-0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1365-2133.2002.4653_4.x","article-title":"Dermatological complications of etanercept therapy for rheumatoid arthritis","volume":"146","author":"Misery","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0016|dth1538-cit-0016","first-page":"2287","article-title":"Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0017|dth1538-cit-0017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/rheumatology\/41.1.116","article-title":"Etanercept and infliximab associated with cutaneous vasculitis","volume":"41","author":"McCain","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0018|dth1538-cit-0018","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0019|dth1538-cit-0019","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5414\/CNP62234","article-title":"Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis","volume":"62","author":"Doulton","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0020|dth1538-cit-0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780360812","article-title":"Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus","volume":"36","author":"Aderka","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0021|dth1538-cit-0021","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/rheumatology\/33.5.428","article-title":"Elevated serum levels of TNF soluble receptors in patients with positive anti-neutrophil cytoplasmic antibodies","volume":"33","author":"Roux-Lombard","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0022|dth1538-cit-0022","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0023|dth1538-cit-0023","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.arbres.2010.05.011","article-title":"Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review","volume":"47","author":"Gifre","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1111\/j.1529-8019.2012.01538.x-BIB0024|dth1538-cit-0024","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/rheumatology\/keq101","article-title":"Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis","volume":"49","author":"Parekh","year":"2010","journal-title":"Rheumatology (Oxford)"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01538.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01538.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T06:47:32Z","timestamp":1688021252000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01538.x"}},"subtitle":["Etanercept-induced Wegener granulomatosis"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01538.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}